This Amendment No. 1 (Amendment No. 1) amends and supplements the Issuer Tender Offer
Statement on Schedule TO filed on July 17, 2024 (the Schedule TO) by BlackRock Capital Allocation Term Trust, a Maryland statutory trust (the Fund), pursuant to Rule 13e-4 under
the Securities Exchange Act of 1934, as amended (the Exchange Act), in connection with an offer by the Fund (the Offer) to repurchase 2.5% of its issued and outstanding common shares of beneficial interest, par value $0.001
per share (the Shares), in exchange for cash at a price equal to 98% of the net asset value (NAV) per Share determined as of the close of the regular trading session of the New York Stock Exchange, the principal market on
which the Shares are traded, on the next day the NAV is calculated after the Offer expires, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated July 17, 2024 (the Offer to Purchase), and in the
related Letter of Transmittal, copies of which were previously filed as Exhibits (a)(1)(i) and (a)(1)(ii), respectively, to the Schedule TO.
This
Amendment No. 1 is being filed to update Item 12 of the Schedule TO to include a press release announcing the preliminary results of the Offer, which expired on August 16, 2024, at 5:00 p.m. Eastern time. A copy of the press release is
attached hereto as Exhibit (a)(5)(ii).
Except as specifically provided herein, the information contained in the Schedule TO, the Offer to Purchase and
the Letter of Transmittal remains unchanged and this Amendment No. 1 does not modify any of the information previously reported in the Schedule TO, the Offer to Purchase or the Letter of Transmittal.
Item 1 through Item 9 and Item 11
The information
set forth in the Offer to Purchase and the related Letter of Transmittal is incorporated by reference into this Amendment No. 1 in answer to Item 1 through Item 9 and Item 11 of the Schedule TO.
Item 10. |
Financial Statements |
(a) The audited annual financial statements of the Fund dated December 31, 2023 and the schedule of investments of the Fund dated
December 31, 2023, both filed with the SEC on EDGAR on Form N-CSR on March 6, 2024, are incorporated by reference. The unaudited semi-annual financial statements of the Fund dated June 30, 2023
and the schedule of investments of the Fund dated June 30, 2023, both filed with the SEC on EDGAR on Form N-CSRS on September 1, 2023, are incorporated by reference.
(b) Not applicable.
Item 12(a) of the Schedule TO is hereby amended and supplemented to add the following exhibit:
(a)(5)(ii) Press release issued on August 16, 2024 is filed herewith.
Filing Fee Exhibit is filed herewith.
Item 13. |
Information Required By Schedule 13E-3 |
Not applicable.
- 2 -